Francisco J. Novoa

Dr. Francisco J. Novoa


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2021 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
PCPaula Carracedo-Reboredo
Paula Carracedo-Reboredo
JLJose Liñares-Blanco
Jose Liñares-Blanco
Nereida Rodriguez-FernandezNereida Rodriguez-Fernandez
Nereida Rodriguez-Fernandez
FCFrancisco Abel Cedrón-Santaeufemia
Francisco Abel Cedrón-Santaeufemia
FNFrancisco J. Novoa
Francisco J. Novoa
Carlos Fernandez-LozanoCarlos Fernandez-Lozano
Carlos Fernandez-Lozano
• Machine Learning in drug discovery has greatly benefited the pharmaceutical industry. • Application of machine algorithms must entail a robust design in real clinical tasks. • Trending machine learning algorithms in drug design: NB, SVM, RF and ANN.

10 June 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
FCFidel Cacheda
Fidel Cacheda
DIDiego Fernández Iglesias
Diego Fernández Iglesias
FNFrancisco J. Novoa
Francisco J. Novoa
VDVictor Manuel Carneiro Díaz
Victor Manuel Carneiro Díaz
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Major Depressive Disorder (MDD) or depression is among the most prevalent psychiatric disorders, affecting more than 300 million people worldwide. Early detection is critical for rapid intervention, which can potentially reduce the escalation of the disorder. Objective: This study used data from social media networks to explore various methods of early detection of MDDs based on analysis with artificial intelligence. Methods: Our best performing method is based on a dual approach that uses a machine learning model to detect depressed subjects and another model to identify non-depressed individuals. Results: The results of a thorough evaluation of the method following a time-aware approach that rewards early detections demonstrate that the dual model can improve current state-of-the-art detection models by more than 10%. Conclusions: Given the results, we consider that this work can help in the development of new solutions to deal with the early detection of depression on social networks.

1 May 2021 in Future Generation Computer Systems
Verified
Journal Article
Open access
MLManuel F. López-Vizcaíno
Manuel F. López-Vizcaíno
FNFrancisco J. Novoa
Francisco J. Novoa
VCVictor Carneiro
Victor Carneiro
FCFidel Cacheda
Fidel Cacheda

1 April 2020 in Atherosclerosis
Verified
Journal Article
Closed access
ILIlse K. Luirink
Ilse K. Luirink
BHBarbara A. Hutten
Barbara A. Hutten
SGSusanne Greber-Platzer
Susanne Greber-Platzer
GKGenovefa D Kolovou
Genovefa D Kolovou
EDEldad J. Dann
Eldad J. Dann
JGJaap W. Groothoff
Jaap W. Groothoff

1 November 2015 in Applied Soft Computing
Verified
Journal Article
Closed access
CCCarmelo del Coso
Carmelo del Coso
DFDiego Fustes
Diego Fustes
Carlos DafonteCarlos Dafonte
Carlos Dafonte
FNFrancisco J. Novoa
Francisco J. Novoa
JRJosé M. Rodríguez-Pedreira
José M. Rodríguez-Pedreira
BABernardino Arcay
Bernardino Arcay

1 January 2012 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
MBMauro Boronat
Mauro Boronat
PSPedro Saavedra
Pedro Saavedra
NPNuria Perez
Nuria Perez
MLMaría J López-Madrazo
María J López-Madrazo
CRCarlos Rodríguez-Pérez
Carlos Rodríguez-Pérez
FNFrancisco J. Novoa
Francisco J. Novoa
Recent data suggest that concentrations of lipoprotein(a) [Lp(a)] may be inversely associated with the risk of diabetes. This study analyzed the relationships between Lp(a) and both diabetes and insulin resistance in an adult cohort from the island of Gran Canaria, Spain.